KEAP1 and bacterial infectious disease: Itaconate acts on Nrf2/Keap1 to exert antioxidant and anti-inflammatory effects, negatively modulates STING pathways to play an antiviral and bacterial infection role, and inhibition of ferroptosis can play a role in lipid peroxidation-related degenerative diseases.